Abstract

Clostridium difficile is the most common identified pathogen causing nosocomial and antibiotic-associated diarrhea. The incidence of Clostridium difficile infection (CDI) has increased over the last decades. The occurrence of severe and recurrent CDI is also more often recently observed. Patients after solid organs transplantation are more prone to Clostridium difficile infection that the general population. This is associated mainly with immunosuppressive therapy, more frequent hospitalizations and frequent antibiotic therapy. Due to the growing number of CDI, it is important to correctly diagnose this infection and to implement the proper treatment. The main drugs used to treat CDI are vancomycin and fidaxomicin. In the case of CDI recurrence, fecal microbiota transplantation remains to be considered. The rationale use of antibiotics and avoiding proton pump inhibitors may also prevent CDI. Results of recent observational study suggest that one of the probiotics – Lactobacillus plantarum 299v prevents CDI in patients during immunosuppressive therapy. The efficacy and safety of using probiotics in CDI prophylaxis in this group of patients requires, however, further studies.

References

• 1. Adawi D., Molin G., Ahrné S., Jeppsson B.: Safety of the probioticstrain Lactobacillus plantarum DSM 9843 (=strain 299v) in an endocarditisanimal model. Microb. Ecol. Health Dis., 2002; 14: 50–53
  Google Scholar
• 2. Alonso C.D., Kamboj M.: Clostridium difficile infection (CDI) in solidorgan and hematopoietic stem cell transplant recipients. Curr.Infect. Dis. Rep., 2014; 16: 414
  Google Scholar
• 3. Ananthakrishnan A.N.: Clostridium difficile infection: epidemiology,risk factors, and management. Nat. Rev. Gastroenterol. Hepatol.,2011; 8: 17–26
  Google Scholar
• 4. Bartlett J.G., Gerding D.N.: Clinical recognition and diagnosis ofClostridium difficile infection. Clin. Infect. Dis., 2008; 46: 12–18
  Google Scholar
• 5. Boutros M., Al-Shaibi M., Chan G.,Cantarovich M., Rahme E., ParaskevasS., Deschenes M., Ghali P., Wong P., Fernandez M., GiannettiN., Cecere R., Hassanain M., Chaudhury P., Metrakos P., TchervenkovJ., Barkun J.S.: Clostridium difficile colitis: increasing incidence, riskfactors, and outcomes in solid organ transplant recipients. Transplantation,2012; 93: 1051–1057
  Google Scholar
• 6. Burke K.E, Lamont J.T.: Clostridium difficile infection: a worldwidedisease. Gut Liver, 2014; 8: 1–6
  Google Scholar
• 7. Caroff D.A., Edelstein P.H., Hamilton K., Pegues D.A., CDC PreventionEpicenters Program: The Bristol stool scale and its relationshipto Clostridium difficile infection. J. Clin. Microbiol., 2014; 52: 3437–3439
  Google Scholar
• 8. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonaldL.C., Pepin J., Wilcox M.H., Society for Healthcare Epidemiologyof America, Infectious Diseases Society of America: Clinical practiceguidelines for Clostridium difficile infection in adults: 2010 update bythe Society for Healthcare Epidemiology of America (SHEA) and theInfectious Diseases Society of America (IDSA). Infect. Control. Hosp.Epidemiol., 2010; 31: 431–455
  Google Scholar
• 9. Collini P.J., Bauer M., Kuijper E., Dockrell D.H.: Clostridium difficileinfection in HIV-seropositive individuals and transplant recipients.J. Infect., 2012; 64: 131–147
  Google Scholar
• 10. Desai K., Gupta S.B., Dubberke E.R., Prabhu V.S., Browne C., MastT.C.: Epidemiological and economic burden of Clostridium difficile inthe United States: Estimates from a modeling approach. BMC Infect.Dis., 2016; 16: 303
  Google Scholar
• 11. Dubberke E.R., Burdette S.D., AST Infectious Diseases Communityof Practice: Clostridium difficile infections in solid organ transplantation.Am. J. Transplant., 2013; 13: S42–S49
  Google Scholar
• 12. Dudzicz S., Kujawa-Szewieczek A., Kwiecień K., Więcek A., AdamczakM.: Lactobacillus plantarum 299v reduces the incidence of Clostridiumdifficile infection in nephrology and transplantation ward – resultsof one year extended study. Nutrients, 2018;10: E1574
  Google Scholar
• 13. Freeman J., Bauer M.P., Baines S.D., Corver J., Fawley W.N., GoorhuisB., Kuijper E.J., Wilcox M.H.: The changing epidemiology ofClostridium difficile infections. Clin. Microbiol. Rev., 2010; 23: 529–549
  Google Scholar
• 14. Friedman-Moraco R.J., Mehta A.K., Lyon G.M., Kraft C.S.: Fecalmicrobiota transplantation for refractory Clostridium difficile colitisin solid organ transplant recipients. Am. J. Transplant., 2014;14: 477–480
  Google Scholar
• 15. Gateau C., Cauturier J., Coia J., Barbut F.: How to: diagnose infectioncaused by Clostridium difficile. Clin. Microbiol. Infect., 2018;24: 463–468
  Google Scholar
• 16. Honda H., Dubberke E.R.: Clostridium difficile infection in solidorgan transplant recipients. Curr. Opin. Infect. Dis., 2014; 27: 336–341
  Google Scholar
• 17. Khanna S., Pardi D.S.: Clostridium difficile infection: New insightsinto management. Mayo Clin. Proc., 2012; 87: 1106–1117
  Google Scholar
• 18. Kochan P., Chmielarczyk A., Szymaniak L., Brykczynski M., GalantK., Zych A., Pakosz K., Giedrys-Kalemba S., Lenouvel E., HeczkoP.B.: Lactobacillus rhamnosus administration causes sepsis in a cardiosurgicalpatient – is the time right to revise probiotic safety guidelines?Clin. Microbiol. Infect., 2011; 17: 1589–1592
  Google Scholar
• 19. Kujawa-Szewieczek A., Adamczak M., Kwiecień K., Dudzicz S.,Gazda M., Więcek A:. The effect of Lactobacillus plantarum 299v on theincidence of Clostridium difficile infection in high risk patients treatedwith antibiotics. Nutrients, 2015; 7: 10179–10188
  Google Scholar
• 20. Kujawa-Szewieczek A., Adamczak M., Kwiecień K., Dudzicz S.,Prażak Z., Więcek A.: Analysis of Clostridium difficile infections inpatients hospitalized at the nephrological ward in Poland. PostępyHig. Med. Dośw., 2016; 70: 505–513
  Google Scholar
• 21. Kulkarni H.S., Khoury C.C.: Sepsis associated with Lactobacillusbacteremia in a patient with ischemic colitis. Indian. J. Crit. CareMed., 2014; 18: 606–608
  Google Scholar
• 22. Leffler D.A., Lamont J.T.: Clostridium difficile infection. N. Engl. J.Med., 2015; 372: 1539–1548
  Google Scholar
• 23. Lessa F.C., Gould C.V., McDonald L.C.: Current status of Clostridiumdifficile infection epidemiology. Clin. Infect. Dis., 2012; 55: S65–S70
  Google Scholar
• 24. Lessa F.C., Mu Y., Bamberg W.M., Beldavs Z.G., Dumyati G.K., DunnJ.R., Farley M.M., Holzbauer S.M., Meek J.I., Phipps E.C., Wilson L.E.,Winston L.G., Cohen J.A., Limbago B.M., Fridkin S.K., Gerding D.N.,McDonald L.C.: Burden of Clostridium difficile infection in the UnitedStates. N. Engl. J. Med., 2015; 372: 825–834
  Google Scholar
• 25. Lin S.C., Alonso C.D., Moss A.C.: Fecal microbiota transplantationfor recurrent Clostridium difficile infection in patients with solidorgan transplants: An institutional experience and review of theliterature. Transpl. Infect. Dis., 2018; 20: e12967
  Google Scholar
• 26. Lyon S.A., Hutton M.L., Rood J.I., Cheung J.K., Lyras D.: CdtRregulates TcdA and TcdB production in Clostridium difficile. PLoSPathog., 2016; 12: e1005758
  Google Scholar
• 27. McDonald L.C., Gerding D.N., Johnson S., Bakken J.S., CarrollK.C., Coffin S.E., Dubberke E.R., Garey K.W., Gould C.V., Kelly C., Loo V., Shaklee Sammons J., Sandora T.J., Wilcox M.H.: Clinical practiceguidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA)and Society for Healthcare Epidemiology of America (SHEA). Clin.Infect. Dis., 2018; 66: e1–e48
  Google Scholar
• 28. Miller B.A., Chen L.F., Sexton D.J., Anderson D.J.: Comparison ofthe burdens of hospital-onset, healthcare facility-associated Clostridiumdifficile infection and of healthcare-associated infection due tomethicillin-resistant Staphylococcus aureus in community hospitals.Infect. Control. Hosp. Epidemiol., 2011; 32: 387–390
  Google Scholar
• 29. Muñoz P., Giannella M., Alcalá L., Sarmiento E., Fernandez YañezJ., Palomo J., Catalán P., Carbone J., Bouza E.: Clostridium difficile-associateddiarrhea in heart transplant recipients: Is hypogammaglobulinemiathe answer? J. Heart. Lung Transplant., 2007; 26: 907–914
  Google Scholar
• 30. Nanwa N., Kendzerska T., Krahn M., Kwong J.C., Daneman N.,Witteman W., Mittmann N., Cadarette S.M., Rosella L., Sander B.:The economic impact of Clostridium difficile infection: A systematicreview. Am. J. Gastroenterol., 2015; 110: 511–519
  Google Scholar
• 31. Pant C., Anderson M.P., O’Connor J.A., Marshall C.M., DeshpandeA., Sferra T.J.: Association of Clostridium difficile infection withoutcomes of hospitalized solid organ transplant recipients: Resultsfrom the 2009 Nationwide Inpatient Sample database. Transpl. Infect.Dis., 2012; 14: 540–547
  Google Scholar
• 32. Paudel S., Zacharioudakis I.M., Zervou F.N., Ziakas P.D., MylonakisE.: Prevalence of Clostridium difficile infection among solid organtransplant recipients: A meta-analysis of published studies. PLoSOne, 2015; 10: e0124483
  Google Scholar
• 33. Poutanen S.M., Simor A.E.: Clostridium difficile-associated diarrheain adults. CMAJ, 2004; 171: 51–58
  Google Scholar
• 34. Poxton I.R., McCoubrey J., Blair G.: The pathogenicity of Clostridiumdifficile. Clin. Microbiol. Infect., 2001; 7: 421–427
  Google Scholar
• 35. Riddle D.J., Dubberke E.R.: Clostridium difficile infection in solidorgan transplant recipients. Curr. Opin. Organ Transplant., 2008;13: 592–600
  Google Scholar
• 36. Smits W.K., Lyras D., Lacy D.B., Wilcox M.H., Kuijper E.J.: Clostridiumdifficile infection. Nat. Rev. Dis. Primers, 2016; 2: 16020
  Google Scholar
• 37. Tariq R., Singh S., Gupta A., Pardi D.S., Khanna S.: Associationof gastric acid suppression with recurrent Clostridium difficile infection:A systematic review and meta-analysis. JAMA Intern. Med.,2017; 177: 784–791
  Google Scholar
• 38. Van den Nieuwboer M., Brummer R.J., Guarner F., Morelli L.,CabanaM., Claasen E.: The administration of probiotics and synbioticsin immune compromised adults: Is it safe? Benef. Microbes,2015; 6: 3–17
  Google Scholar
• 39. Van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., ZoetendalE.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., TijssenJ.G., Speelman P., Dijkgraaf M.G., Keller J.J.: Duodenal infusion ofdonor feces for recurrent Clostridium difficile. N. Engl. J. Med., 2013;368: 407–415
  Google Scholar
• 40. Zilberberg M.D., Shorr A.F., Kollef M.H.: Increase in adult Clostridiumdifficile-related hospitalizations and case-fatality rate, UnitedStates, 2000–2005. Emerg. Infect. Dis., 2008; 14: 929–931
  Google Scholar

Full text